Previous 10 | Next 10 |
Anika Therapeutics ( ANIK +5.2% ) appoints Cheryl Blanchard as President and CEO, effective immediately More news on: Anika Therapeutics, Inc., Healthcare stocks news, Read more ...
Seasoned industry executive with experience leading global joint preservation and restoration businesses Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) ...
Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its first quarter 2020 financial results after the close of the market on Thursday, May 7, 2020 and hold its investor conference call on the same day, Thursday, May 7, 2020, at 5:00 p.m. ET to discuss it...
Aimed at strengthening its financial position during the uncertainties associated with the current pandemic, Anika Therapeutics (NASDAQ: ANIK ) is drawing $50M from its existing credit facility, beefing up its total liquidity to ~$140M. More news on: Anika Therapeutics, Inc., Healthcare ...
BEDFORD, Mass., April 08, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (“HA”) technology platform , today provided an u...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2019 Q4 earnings Read more ...
Anika Therapeutics (NASDAQ: ANIK) delivered its fourth-quarter earnings report Thursday night , beat Wall Street's consensus estimates on both the top and bottom lines The medical technology company, which focuses on the $7 billion sports and regenerative medicine market, offers produ...
Image source: The Motley Fool. Anika Therapeutics Inc (NASDAQ: ANIK) Q4 2019 Earnings Call Feb 20, 2020 , 5:00 p.m. ET Operator Continue reading
Anika Therapeutics, Inc. (ANIK) Q4 2019 Earnings Conference Call February 20, 2020, 17:00 ET Company Participants Sylvia Cheung - CFO, Treasurer & Secretary Cheryl Blanchard - Interim CEO & Director James Loerop - EVP, Business Development & Strategic Planning Conf...
Anika Therapeutics (NASDAQ: ANIK ): Q4 Non-GAAP EPS of $0.43 beats by $0.01 ; GAAP EPS of $0.28 misses by $0.14 . More news on: Anika Therapeutics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ:ANIK), a global joint preservation company in early interven...
BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2024 financial results after the close of the market on Wednesda...
2024-04-09 16:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...